ICH Q3E: A New Risk-Based Framework for Extractables and Leachables in Pharmaceutical Products

Understand How The Draft ICH Q3E Guideline Could Influence Your E&L Testing Strategy

Protecting patient safety and product quality starts with understanding the substances that could migrate into your pharmaceutical product from manufacturing systems, packaging and delivery devices.

This technical paper explores the proposed ICH Q3E framework and its potential implications for your extractables and leachables (E&L) programme. Gain a clearer understanding of the analytical and toxicological considerations that inform risk assessment, study design and ongoing lifecycle management.

ICH Q3E: A New Risk-Based Framework for E&L in Pharma Products - Cover Image

Why Download?

  • Understand the proposed framework and what draft ICH Q3E could mean for your E&L programme.
  • Inform your testing strategy with insight into extractables, leachables and simulated leachables studies.
  • Clarify key safety considerations, including analytical thresholds, leachable classification and patient exposure.
  • Plan for lifecycle changes by understanding how materials, suppliers and product modifications can affect E&L risk.

Expert Insight From Cormica

Written by Luminita Moraru, Technical Leader – Medical Device Chemistry, the content draws on Cormica’s scientific expertise in chemical characterisation and E&L assessment.

Our expert scientists bring decades of experience supporting clients worldwide, helping manufacturers understand their products’ critical quality attributes.

Download The Free Technical Paper

Complete the form to access your PDF copy and explore what the proposed framework could mean for your E&L strategy.

Have a specific project in mind? Discuss your testing requirements with our team.

Download:

We will email you the link to the PDF file.

Facebook
X
LinkedIn
Email
WhatsApp
Print

Author:

Luminita Moraru is Medical Device Chemistry Technical Lead at Cormica Bradford, with extensive experience in Extractables &; Leachables (E&L), chemical characterisation and biocompatibility. An expert committee member for ISO 10993 and ISO 18562, she specialises in designing studies to support medical device safety assessments and regulatory compliance.

Laboratories near you, supporting global product success

With accredited laboratories in the UK, EU and US, we support pharmaceutical, medical device and combination product manufacturers worldwide. Local support combined with global quality, delivered by teams who understand your regulatory requirements.

Cormica Award winning Testing laboratories
Cormica Global Map locations (1)

Our Clients’ Experiences

Scroll to Top